Indications of the new drug Siponimod

The new drug Siponimod is mainly used to treat relapsing multiple sclerosis in adults, which is a chronic inflammatory autoimmune disease. The patient's immune system mistakenly attacks the myelin sheath that protects nerves, causing damage to the nervous system and affecting the communication of information between the brain and other parts of the body. Siponimod can alter the course of the disease by reducing the number of peripheral blood lymphocytes, preventing neurodegeneration at synapses, and promoting remyelination in the central nervous system. This innovative medicine provides people with multiple sclerosis with a new treatment option to help better manage symptoms and improve quality of life.